CD274 and cancer: A total of seven KEGG pathways had been enriched, including the T-cell receptor signaling pathway, primary immunodeficiency, PD-L1 expression and PD-1 checkpoint pathway in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Yersinia infection, and cell adhesion molecules.